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Equilenin, a naturally fluorescent steroid, has high binding affinity for human sex steroid-binding protein 
(SBP). At 4°C the equilibrium association constant is -6 x 107M-‘. The fluorescence excitation and 
emission spectra of the steroid-protein complex indicate that both hydrophobic interactions and hydrogen 
bonding of the 3’-hydroxyl group of the estrogen are important in its binding to the protein. Equilenin 
has a substantially different 3-dimensional spatial configuration compared with the normally bound 
androgens, and yet exhibits very tight binding to SBP. This suggests that SBP undergoes a conformational 
change to accomodate quilenin. 
Equilenin Sex steroid-binding protein 
1. INTRODUCTION 
The sex steroid-binding protein @BP) specifical- 
ly binds sex-steroids in the plasma. The human and 
non-human primate proteins have greatest affinity 
for Sa-dihydrotestosterone and testosterone, but 
also bind, with less affinity 17,&estradiol [l-3]. 
The rabbit protein does not bind 17,&estradiol 
significantly [l]. Methods for obtaining pure SBP 
have been difficult to establish, but early efforts 
yielded enough material to begin physico-chemical 
characterization [4-71. Improvements in the design 
of a steroid-agarose adsorbent have greatly in- 
creased the yield of pure protein, and it is now 
possible to isolate lo-15 mg/preparation, thereby 
greatly accelerating physico-chemical characteriza- 
tion [8]. The research developments on SBP and on 
other extra-cellular androgen-binding proteins 
have been reviewed [9]. The information on SBP 
Address correspondence to J.B.A.R. and P.H.P. 
The competition of a variety of steroids with 
[3H]testosterone for binding to partially-purified 
preparations of human SBP was compared in [ 111. 
Equilenin, an estrogen isolated from horse urine, 
was among these steroids. This steroid was 
reported to have 33% binding to human SBP 
relative to testosterone, suggesting a binding con- 
stant somewhat > lo7 M-l. 
Preliminary account presented at the Tenth Annual Equilenin is of special interest because rings A 
Meeting of the American Society for Photobiology, and B are aromatic, containing a 3 ‘-hydroxyl 
Vancouver, June 1982; abst. PS-B-11. group. The aromatic structure is that of 2-naph- 
Fluorescence Steroid-protein interaction 
has been updated with new findings about the 
molecular organization of SBP and the role of the 
protein in plasma [lo]. 
We are interested in developing fluorescent pro- 
bes for examining the nature of the steroid-protein 
interaction in pure SBP. One possible way is by 
covalently linking dyes to dihydrotestosterone 
analogues. Another way is to utilize fluorescent 
steroids which exhibit high affinity. Since the 
ground and excited states of aromatic molecules 
are very sensitive to the local environment, 
fluorescence studies have the potential of pro- 
viding considerable information about the nature 
of the steroid binding site in SBP. 
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thol, a strongly fluorescent molecule with well-cha- 
racterized excited state properties. 2-Naphthol 
undergoes a two-state exicted-state reaction, name- 
ly loss of the hydroxylic proton, which is pH- 
dependent and affected by various proton accep- 
tors [12]. Furthermore, the absorption spectrum of 
equilenin permits excitation of the steroid in- 
dependently of the protein tryptophan residues. 
These spectral properties make equilenin useful as 
a fluorescent binding site probe for SBP. 
Here, we have determined the equilibrium 
association constant of equilenin to human SBP, 
and report the steady state fluorescence excitation 
and emission spectra of equilenin in the SBP com- 
plex. This should establish the steroid as a fluor- 
escent probe to study the steroid-protein inter- 
action. 
2. EXPERIMENTAL 
2.1. Chemicals 
Equilenin was purchased from Sigma. All other 
chemicals were reagent grade and used without fur- 
ther purification. Other materials used were as in 
[5,6,81. 
2.2. Methods 
Human SBP, from fresh pregnancy serum, was 
isolated as in [8]. The pure protein was stored 
frozen at -20°C in a 1OmM Tris buffer (pH7.4), 
containing 0.1 M NaCl, 5 mM CaC12, 20pM di- 
hydrotestosterone (DHT) and 10% glycerol (v/v). 
The binding affinity of equilenin to SBP was 
determined by a filter assay [ 131. This method 
measures the competitive binding between 
[ ‘H]DHT and non-radiolabeled steroid. 
The equilenin complex with purified SBP was 
prepared by dialysis against he Tris buffer describ- 
ed above, except hat 2pM equilenin replaced DHT 
and 10% sucrose (w/v) replaced glycerol. No 
steroid was used in the final three changes of buf- 
fer. In this way most of the weakly bound and free 
steroid was removed. 
Uncorrected fluorescence spectra of the SBP- 
equilenin complex were carried out using a Perking 
Elmer MPF 44A spectrofluorometer equipped with 
a thermostated cuvette holder. The typical excita- 
tion and emission bandpass was 5 nm. Conditions 
for the spectral measurements are given in the 
figures. 
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Fig. 1. Determination of the equilibrium association 
constants of DHT and equilenin binding to SBP in 
human serum at 4”C, as in [12]. The association 
constant of equilenin (Ki) was calculated from the 
apparent association constant (Kp) of DHT in the 
presence of 5.8 x lo-‘M equilenin (A) and the 
association constant (Ka) of DHT alone (O), as 
explained in the text. 
3. RESULTS 
3.1. Equilenin binding to SBP in human serum 
Fig. 1 shows a competitive Scatchard plot from 
which the equilibrium association, at 4”C, of 
[3H]DHT to SBP is obtained. The equilibrium 
association constant (Ki) for equilenin, the com- 
peting steroid, is calculated from the relationship: 
Ka = Kp (1 + Ki[S]) 
where: 
K, = the association constant for DHT; 
KD = the apparent association constant reduced by 
a given concentration of the competing ste- 
roid, S. 
Fitting the data by linear least squares yields a 
K, value of 3 + 1 x lo9 M-’ for DHT, in good 
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agreement with the reported value of 
2.8 + 0.6 x lo9 M-’ [13]. In the presence of 
5.8 x 10m8 M equilenin, a K,, value of 
7.04 + 0.04 x lo8 M-r is obtained. Accordingly, 
the calculated binding constant for equilenin (Ki) is 
5.7 f 1.9 x lO’M_‘, about a factor of 50 than for 
DHT. 
3.2. Equilenin complex with pure human SBP 
Formation of the equilenin-SBP complex was 
carried out by dialysis. Inside the dialysis bag SBP 
was 5 x 10e6 M, determined by the 280nm extinc- 
tion coefficient of -9OOOOcm-‘. M-’ [l]. After 
further dialysis in the absence of steroid, the 
280nm absorbance of the protein solution was 
slightly higher than before dialysis in the presence 
of equilenin, indicating essentially no loss of SBP 
and that, in addition, equilenin was apparently 
bound. The protein solution had a new absorbance 
peak at 340nm, not present prior to dialysis. The 
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Fig. 2. Comparison of fluorescence mission spectra of 
equilenin bound to SBP and free in buffer, excited at 
330nm. The emission spectrum of SBP saturated with 
DHT, excited at 280 nm, shows the spectral distribution 
of the tryptophan fluorescence. All of the data were 
Fig. 3. Comparison of the excitation spectra, monitored 
at 4OOnm, of equilenin bound to SBP, equilenin free in 
solution, and the equilenin-SBP complex after addition 
of saturating DHT (20pM). The experimental conditions 
obtained at 2O”C, as described in the text. are as in fig. 2. 
242 
precise ratio of equilenin to SBP was difficult to 
determine since the absorbance of the 340 nm peak 
was small (-0.01). However, using the 340nm ex- 
tinction coefficient determined for equilenin in 
ethanol (25OOcm-‘.M-r), we estimate that 1 mol 
equilenin/mol SBP is bound, as is the case with 
DHT binding [13]. Free equilenin in the dialysate 
was not detectable by absorbance measurement. 
However, a weak equilenin fluorescence, <0.5% 
that of the sample, was observed. 
3.3. Fluorescence mission and excitation spectra 
The fluorescence emission spectra of free 
equilenin and that bound to SBP are compared in 
fig. 2. Excitation was at 330nm to avoid contri- 
bution from tryptophan; SBP has a tryptophan 
absorbance with a red ‘tail’ extending to 
-3 10-3 15 nm. The 280 nm excited tryptophan 
emission spectrum of the protein, prior to dialysis 
with equilenin, is also in fig. 2. 
1 hSBP. equilenin 
2. DHT added 
3 free equilenin 
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The fluorescence excitation spectrum of the 
complex, shown in fig. 3, is essentially due to the 
absorption of equilenin and of tryptophan in SBP. 
Addition of DHT to the equilenin-SBP complex 
dramatically alters the fluorescence excitation 
spectrum. Although tryptophan excitation, moni- 
tored at 4OOnm, is still evident after addition of 
equilenin, the intensity of the entire excitation 
spectrum decreases. The spectral envelope above 
300nm is blue-shifted and superimposes on the 
free equilenin spectrum. Moreover, the fluor- 
escence mission excited at 330 nm is identical with 
that of free equilenin. These results show that 
DHT effectively displaces equilenin, and that the 
remaining contribution of tryptophan below 
300nm is largely due to the SBP-DHT complex. 
4. DISCUSSION 
These results show that equilenin can serve as a 
potentially useful probe for studying the steroid 
-protein interaction. The equilibrium association 
constant of -6 x lO’M_’ is sufficiently strong to 
displace the natural steroid, DHT, from the bin- 
ding site. The value for the association constant 
obtained by the competitive filter assay [ 131 agrees 
well with the binding measured at one concentra- 
tion of the inhibitor [ 111. Such a strong interaction 
between equilenin and SBP was somewhat unex- 
pected because of the significant difference in the 
3-dimensional spatial structure between equilenin 
and DHT. This means that aromatic residues may 
be important in the binding interaction by pro- 
viding planar hydrophobic surfaces which can in- 
duce conformational changes in the structure of 
the protein. The equilenin absorption at 340nm 
has good overlap with the tryptophan emission at 
337 nm, ideal for singlet-singlet energy-transfer 
measurements which can provide insight into the 
role of tryptophan and tryrosine residues near or in 
the steroid binding site. 
The direction of the fluorescence wavelength 
shifts and the intensity changes of bound vs free 
equilenin reveals significant information about the 
SBP steroid binding site. The excitation spectrum 
above 300 nm of the bound species is similar to that 
of equilenin in neutral ethanol, and is red-shifted 
with respect to the spectrum in more polar, 
aqueous buffer. Since the high pH excitation spec- 
trum of free equilenin is red-shifted due to ground 
state ionization of the 3 ‘-hydroxyl group, the red- 
shift in the complex could be due either to a hydro- 
phobic binding site or to hydrogen bonding of the 
A ring hydroxyl group with an amino acid residue. 
We will discuss both possibilities. 
The fluorescence emission of planar aromatic 
molecules bound to many proteins is blue-shifted 
compared to the emission in water. The similarity 
of the bound fluorophore’s spectra to its spectra in 
less polar solvents is generally ascribed to a 
hydrophobic environment in the binding site. 
From the excitation spectrum of the complex we 
have argued that the steroid binding site may be 
hydrophobic. However, the emission spectrum of 
the complex is red-shifted by > lOnm, suggestive 
of hydrogen bonding or excited state ionization. 
The emission spectrum of free equilenin becomes 
broadened and progressively red-shifted at pH > 8 
as the excited state equilibrium is shifted more 
towards the ionized form of the steroid. Equilenate 
is less fluorescent than equilenin and has its max- 
imum near 420nm. Since the emission of the 
equilenin-SBP complex is similar to the pH 9 spec- 
trum of the free steroid, it appears that the steroid 
is hydrogen-bonded in its binding site, and that the 
fluorescence emission is due to a mixture of emit- 
ting species depending upon the degree of ioniza- 
tion in the excited state. But since the emission of 
the free steroid in basic ethanol is also red-shifted, 
this argument does not preclude the role of 
hydrophobic interactions in the steroid binding 
site. The overall spectral data indicate that both 
kinds of interactions are present and important for 
the unexpectedly tight binding of equilenin by 
human SBP. The differences in the 3-dimensional 
structure of equilenin compared with either DHT 
or testosterone suggests that the tight binding of 
the estrogen induces a conformational change in 
SBP. 
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